Last Week’s Hot Topic on Pulmonary Hypertension

admin avatar

by admin |

Share this article:

Share article via email


Last week’s hot topic on Pulmonary Hypertension was an article titled PAH Clinical Trial of INOpulse Therapy Shows Benefit, New Phase 3 Study Planned, written by Margarida Azevedo.

This article refers to the recent announcement of the results from the final analysis of the second part of Bellerophon Therapeutics’ Phase 2 clinical trial evaluating INOpulse for the treatment of pulmonary arterial hypertension (PAH), supporting the device’s continued evaluation in an upcoming Phase 3 trial.

The Phase 3 trials are planned to begin this year in Europe and the U.S., using a second-generation INOpulse device, a smaller, lighter and improved version of that used in the now completed studies.

Read more about pulmonary hypertension here: